... And Inks Co-Marketing Alliance with Xantos | GenomeWeb

NEW YORK, Aug. 8 (GenomeWeb News) - Qiagen will co-market its TOM-amidite chemistry-based genome-wide RNAi products with Xantos Biomedicine's automated cell-based screening platform, XantoScreen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.